A study conducted in 2015 suggested that patients with AMPAR antibodies show less substantial recoveries than those with other types of autoimmune encephalitis [NMDAR, LGI1, or GABA(B)R] (4). This evidence concerns the gene LGI1 and autoimmune encephalitis.